title: Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
abstract: A therapeutic goal in the treatment of certain CNS diseases, including multiple sclerosis, amyotrophic lateral sclerosis, and Parkinson disease, is to down-regulate inflammatory pathways. Inflammatory molecules produced by microglia are responsible for removal of damaged neurons, but can cause collateral damage to normal neurons located close to defective neurons. Although estrogen can inactivate microglia and inhibit the recruitment of T cells and macrophages into the CNS, there is controversy regarding which of the two estrogen receptors (ERs), ERα or ERβ, mediates the beneficial effects in microglia. In this study, we found that ERβ, but not ERα, is expressed in microglia. Using the experimental autoimmune encephalomyelitis (EAE) model in SJL/J mice, we evaluated the benefit of an ERβ agonist as a modulator of neuroinflammation. Treatment of EAE mice with LY3201, a selective ERβ agonist provided by Eli Lilly, resulted in marked reduction of activated microglia in the spinal cord. LY3201 down-regulated the nuclear transcription factor NF-κB, as well as the NF-κB-induced gene inducible nitric oxide synthase in microglia and CD3(+) T cells. In addition, LY3201 inhibited T-cell reactivity through regulation of indoleamine-2,3-dioxygenase. In the EAE model, treatment with LY3201 decreased mortality in the first 2 wk after disease onset, and also reduced the severity of symptoms in mice surviving for 4 wk. Our data show that ERβ-selective agonists, by modulating the immune system in both microglia and T cells, offer promise as a useful class of drugs for treating degenerative diseases of the CNS.
authors: Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77204, USA.
authors: Wan-fu
authors: WF
authors: Wu
authors: Xin-jie
authors: XJ
authors: Tan
authors: Yu-bing
authors: YB
authors: Dai
authors: Venkatesh
authors: V
authors: Krishnan
authors: Margaret
authors: M
authors: Warner
authors: Jan-Åke
authors: JÅ
authors: Gustafsson
mesh_terms: D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D015536:Down-Regulation / Q000187:drug effects; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology* / Q000473:pathology; D047628:Estrogen Receptor alpha / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000378:metabolism*; D005260:Female; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism; D051379:Mice; D017628:Microglia / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D058990:Molecular Targeted Therapy; D016328:NF-kappa B / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D013116:Spinal Cord / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology
chemical_list: D001578:Benzopyrans; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D016328:NF-kappa B; C570989:LY3201; D052247:Nitric Oxide Synthase Type II
references: Bioorg Med Chem Lett. 2007 Sep 1;17(17):4824-8
references: 17614275
references: Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13696-701
references: 17693550
references: Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2543-8
references: 15699342
references: J Neural Transm (Vienna). 2010 Aug;117(8):971-9
references: 20571837
references: Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19338-43
references: 17159139
references: Proc Natl Acad Sci U S A. 2012 May 8;109(19):7493-8
references: 22529354
references: Annu Rev Immunol. 2009;27:119-45
references: 19302036
references: Cell. 2011 May 13;145(4):584-95
references: 21565615
references: J Neurol. 2012 Jun;259(6):1199-205
references: 22160466
references: Blood. 2000 May 1;95(9):2875-82
references: 10779434
references: J Mol Med (Berl). 1997 Mar;75(3):165-73
references: 9106073
references: Curr Top Med Chem. 2005;5(10):921-8
references: 16178737
references: Semin Neurol. 2008 Feb;28(1):56-68
references: 18256987
references: Nature. 2007 Jul 26;448(7152):474-9
references: 17568699
references: Nat Rev Immunol. 2002 Oct;2(10):725-34
references: 12360211
references: J Cell Mol Med. 2009 Apr;13(4):631-43
references: 19438970
references: Nitric Oxide. 2010 Sep 15;23(2):75-93
references: 20438856
references: Cell. 2010 Mar 19;140(6):918-34
references: 20303880
references: Endocrinology. 2006 May;147(5):2263-72
references: 16469811
references: Clin Cancer Res. 2005 May 1;11(9):3170-4
references: 15867209
references: Trends Immunol. 2013 Mar;34(3):137-43
references: 23103127
references: Glia. 2002 Nov;40(2):133-9
references: 12379901
references: Endocrinology. 2004 Nov;145(11):5021-32
references: 15256495
references: Nat Immunol. 2006 Sep;7(9):954-61
references: 16892069
references: Nat Rev Immunol. 2005 Oct;5(10):749-59
references: 16175180
references: Cell. 1996 Oct 4;87(1):13-20
references: 8858144
references: J Biol Chem. 2000 Aug 18;275(33):25322-9
references: 10840033
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2528-33
references: 9122229
references: N Engl J Med. 2006 Mar 2;354(9):899-910
references: 16510744
references: Lancet Neurol. 2004 Feb;3(2):104-10
references: 14747002
references: Lancet. 2002 Dec 21-28;360(9350):2018-25
references: 12504397
references: Lab Invest. 2009 Oct;89(10):1076-83
references: 19668239
references: Acta Neuropathol. 2010 Jan;119(1):89-105
references: 20012873
references: J Neuroimmunol. 2007 Nov;191(1-2):16-25
references: 17904645
references: Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20090-4
references: 22114194
references: Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1708-12
references: 22307635
references: Nat Neurosci. 2005 Jun;8(6):752-8
references: 15895084
references: N Engl J Med. 2000 Sep 28;343(13):938-52
references: 11006371
references: Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):187-97
references: 18515173
references: Mol Psychiatry. 2009 Feb;14(2):223-32, 117
references: 18982005
references: Clin Exp Immunol. 1998 Aug;113(2):147-56
references: 9717962
references: Mol Psychiatry. 2013 Jun;18(6):674-80
references: 22665260
references: Science. 2005 May 27;308(5726):1314-8
references: 15831717
references: Ann Neurol. 2007 Nov;62(5):504-14
references: 17879969
references: Ann Neurol. 2007 Jan;61(1):14-24
references: 17262850
references: Neurology. 2005 Apr 26;64(8):1336-42
references: 15851719
references: J Neurol Sci. 2003 Feb 15;206(2):153-5
references: 12559503
references: J Steroid Biochem Mol Biol. 2002 Mar;80(3):291-7
references: 11948013
references: Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13112-7
references: 22826221